Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1977 1
1981 1
1982 4
1985 1
1986 1
1988 1
1989 2
1990 2
1991 3
1992 4
1993 3
1994 2
1995 1
1996 2
1997 5
1998 3
1999 5
2000 3
2001 1
2002 6
2003 2
2005 6
2006 3
2007 2
2008 2
2009 1
2010 3
2011 3
2012 10
2013 7
2014 6
2015 4
2016 6
2017 7
2018 10
2019 8
2020 7
2021 6
2022 5
2023 9
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

141 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Portal hypertension, noncirrhotic, 2"
Page 1
Non-cirrhotic portal hypertension - diagnosis and management.
Khanna R, Sarin SK. Khanna R, et al. J Hepatol. 2014 Feb;60(2):421-41. doi: 10.1016/j.jhep.2013.08.013. Epub 2013 Aug 23. J Hepatol. 2014. PMID: 23978714 Free article. Review.
In EHPVO, there are additional concerns of growth faltering, portal biliopathy, MHE and parenchymal dysfunction. Surgical shunts are indicated in patients with failure of endotherapy, bleeding from sites not amenable to endotherapy, symptomatic hypersplenism or symptomatic …
In EHPVO, there are additional concerns of growth faltering, portal biliopathy, MHE and parenchymal dysfunction. Surgical shunts are …
Non-cirrhotic portal hypertension.
Sarin SK, Khanna R. Sarin SK, et al. Clin Liver Dis. 2014 May;18(2):451-76. doi: 10.1016/j.cld.2014.01.009. Clin Liver Dis. 2014. PMID: 24679506 Review.
Non-cirrhotic portal hypertension (NCPH) encompasses a wide range of disorders, primarily vascular in origin, presenting with portal hypertension (PHT), but with preserved liver synthetic functions and near normal hepatic venous pressure gradient (HVPG …
Non-cirrhotic portal hypertension (NCPH) encompasses a wide range of disorders, primarily vascular in origin, presenting with …
"Porto-pulmonary hypertension: a comprehensive review".
Liberal R, Grant CR, Baptista R, Macedo G. Liberal R, et al. Clin Res Hepatol Gastroenterol. 2015 Apr;39(2):157-67. doi: 10.1016/j.clinre.2014.12.011. Epub 2015 Feb 7. Clin Res Hepatol Gastroenterol. 2015. PMID: 25659878 Review.
Porto-pulmonary hypertension (PoPH) is a rare but threatening vasculopathy, defined by the presence of pulmonary arterial hypertension (PAH) in the setting of portal hypertension. ...PoPH is estimated to occur in 3 to 10% of patients with end-stage liv …
Porto-pulmonary hypertension (PoPH) is a rare but threatening vasculopathy, defined by the presence of pulmonary arterial hyperten …
Performance of non-invasive tests and histology for the prediction of clinical outcomes in patients with non-alcoholic fatty liver disease: an individual participant data meta-analysis.
Mózes FE, Lee JA, Vali Y, Alzoubi O, Staufer K, Trauner M, Paternostro R, Stauber RE, Holleboom AG, van Dijk AM, Mak AL, Boursier J, de Saint Loup M, Shima T, Bugianesi E, Gaia S, Armandi A, Shalimar, Lupșor-Platon M, Wong VW, Li G, Wong GL, Cobbold J, Karlas T, Wiegand J, Sebastiani G, Tsochatzis E, Liguori A, Yoneda M, Nakajima A, Hagström H, Akbari C, Hirooka M, Chan WK, Mahadeva S, Rajaram R, Zheng MH, George J, Eslam M, Petta S, Pennisi G, Viganò M, Ridolfo S, Aithal GP, Palaniyappan N, Lee DH, Ekstedt M, Nasr P, Cassinotto C, de Lédinghen V, Berzigotti A, Mendoza YP, Noureddin M, Truong E, Fournier-Poizat C, Geier A, Martic M, Tuthill T, Anstee QM, Harrison SA, Bossuyt PM, Pavlides M; LITMUS investigators. Mózes FE, et al. Lancet Gastroenterol Hepatol. 2023 Aug;8(8):704-713. doi: 10.1016/S2468-1253(23)00141-3. Epub 2023 Jun 5. Lancet Gastroenterol Hepatol. 2023. PMID: 37290471 Free article.
BACKGROUND: Histologically assessed liver fibrosis stage has prognostic significance in patients with non-alcoholic fatty liver disease (NAFLD) and is accepted as a surrogate endpoint in clinical trials for non-cirrhotic NAFLD. Our aim was to compare the prognostic …
BACKGROUND: Histologically assessed liver fibrosis stage has prognostic significance in patients with non-alcoholic fatty liver disea …
Overlooked subclinical portal hypertension in non-cirrhotic NAFLD: Is it real and how to measure it?
Baffy G, Bosch J. Baffy G, et al. J Hepatol. 2022 Feb;76(2):458-463. doi: 10.1016/j.jhep.2021.09.029. Epub 2021 Oct 2. J Hepatol. 2022. PMID: 34606912 Review.
Although clinically significant portal hypertension (HVPG 10 mmHg) retains its prognostic significance in NASH, subclinical portal hypertension (HVPG 6.0-9.5 mmHg) has been repeatedly detected in patients with NAFLD in the absence of cirrhosis o …
Although clinically significant portal hypertension (HVPG 10 mmHg) retains its prognostic significance in NASH, subclin …
Non-cirrhotic portal hypertension.
[No authors listed] [No authors listed] Lancet. 1981 Dec 5;2(8258):1267-8. Lancet. 1981. PMID: 6118676 No abstract available.
Non-invasive evaluation of portal hypertension using ultrasound elastography.
Berzigotti A. Berzigotti A. J Hepatol. 2017 Aug;67(2):399-411. doi: 10.1016/j.jhep.2017.02.003. Epub 2017 Feb 14. J Hepatol. 2017. PMID: 28223101 Review.
Portal hypertension (PH) leads to serious complications, such as bleeding from gastroesophageal varices, ascites and portosystemic encephalopathy in patients with chronic liver disease (CLD). ...
Portal hypertension (PH) leads to serious complications, such as bleeding from gastroesophageal varices, ascites and portosyst …
Transjugular Intrahepatic Portosystemic Shunt and Thrombectomy (TIPS-Thrombectomy) for Symptomatic Acute Noncirrhotic Portal Vein Thrombosis.
Shalvoy MR, Ahmed M, Weinstein JL, Ramalingam V, Malik MS, Ali A, Shenoy-Bhangle AS, Curry MP, Sarwar A. Shalvoy MR, et al. J Vasc Interv Radiol. 2023 Aug;34(8):1373-1381.e3. doi: 10.1016/j.jvir.2023.05.009. Epub 2023 May 12. J Vasc Interv Radiol. 2023. PMID: 37182668
PURPOSE: To report the safety and effectiveness of transjugular intrahepatic portosystemic shunt and mechanical thrombectomy (TIPS-thrombectomy) for symptomatic acute noncirrhotic portal vein thrombosis (NC-PVT). MATERIALS AND METHODS: Patients with acute NC-PVT who …
PURPOSE: To report the safety and effectiveness of transjugular intrahepatic portosystemic shunt and mechanical thrombectomy (TIPS-thrombect …
Clinical Course of Porto-Sinusoidal Vascular Disease Is Distinct From Idiopathic Noncirrhotic Portal Hypertension.
Wöran K, Semmler G, Jachs M, Simbrunner B, Bauer DJM, Binter T, Pomej K, Stättermayer AF, Schwabl P, Bucsics T, Paternostro R, Lampichler K, Pinter M, Trauner M, Mandorfer M, Stift J, Reiberger T, Scheiner B. Wöran K, et al. Clin Gastroenterol Hepatol. 2022 Feb;20(2):e251-e266. doi: 10.1016/j.cgh.2020.11.039. Epub 2020 Dec 3. Clin Gastroenterol Hepatol. 2022. PMID: 33279774
BACKGROUND & AIMS: Porto-sinusoidal vascular disease (PSVD) was recently proposed as novel clinical entity characterized by typical histological changes with or without portal hypertension (PH) in the absence of cirrhosis. Thus, we aimed to describe clinical cha …
BACKGROUND & AIMS: Porto-sinusoidal vascular disease (PSVD) was recently proposed as novel clinical entity characterized by typical hist …
Clinical features of idiopathic portal hypertension in China: A retrospective study of 338 patients and literature review.
Sun Y, Lan X, Shao C, Wang T, Yang Z. Sun Y, et al. J Gastroenterol Hepatol. 2019 Aug;34(8):1417-1423. doi: 10.1111/jgh.14552. Epub 2018 Dec 16. J Gastroenterol Hepatol. 2019. PMID: 30462857 Review.
BACKGROUND AND AIM: Idiopathic portal hypertension (IPH) refers to a relatively rare condition characterized by intrahepatic portal hypertension in the absence of underlying disease such as liver cirrhosis. ...Medication appears to be an important etio …
BACKGROUND AND AIM: Idiopathic portal hypertension (IPH) refers to a relatively rare condition characterized by intrahepatic …
141 results